Senate Bill 764 aims to establish a cost-sharing cap for epinephrine delivery systems under health insurance policies and self-insured governmental health plans in Wisconsin. The bill stipulates that these policies cannot impose cost-sharing amounts exceeding $60 for two doses of any type of epinephrine delivery system, which is defined as a device approved by the FDA that contains a premeasured dose of epinephrine for administering to individuals experiencing life-threatening allergic reactions. The bill amends existing statutes and creates a new section, 632.895 (12r), to formalize these provisions.

Additionally, the bill clarifies that while the specified cost-sharing cap is mandatory, insurers may choose to impose lower cost-sharing amounts or none at all. The effective date for these changes will be the first day of the fourth month following publication, with specific applicability provisions for policies affected by collective bargaining agreements. The bill also includes amendments to section 609.83 to ensure that limited service health organizations and other defined network plans comply with the new regulations regarding epinephrine delivery systems.

Statutes affected:
Bill Text: 609.83